跳至主要内容
临床试验/ITMCTR2022000020
ITMCTR2022000020招募中1 期

A Prospective Study and mechanism exploration of Tangwang prescription in the Treatment of Non-Proliferative Diabetic Retinopathy

Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Xicheng District, Beijing0 个研究点开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

年龄范围
30 至 70(—)
性别
All

入选标准

  • (1) Meet the diagnostic criteria for type 2 diabetic retinopathy, the degree of the disease is non-proliferative (at least one eye meet)
  • (2) Age 30-70 years

排除标准

  • (1)Other ophthalmic diseases that do not belong to diabetic retinopathy, such as non-diabetic retinopathy, uveitis, retinal detachment, optic nerve disease and high myopia with fundus lesions;
  • (2)meet the diagnostic criteria for diabetic retinopathy, but the degree of the disease was proliferative.
  • (3)Type 1 diabetic retinopathy.

研究者

发起方
Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Xicheng District, Beijing

相似试验